Qrons Selects PCG Advisory for Investor Relations and Strategic Communications as it Advances its Product Candidates
NEW YORK, NY,, Aug. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Qrons Inc. (OTCQB: QRON), an emerging biotechnology company developing advanced stem cell-synthetic hydrogel-based solutions for the treatment of traumatic brain injuries, including …